![](/img/cover-not-exists.png)
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)
Barrera, Carlos M, Mykietiuk, Analia, Metev, Hristo, Nitu, Mimi Floarea, Karimjee, Najumuddin, Doreski, Pablo Alexis, Mitha, Ismail, Tanaseanu, Cristina Mihaela, Molina, Joseph McDermott, Antonovsky,Language:
english
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(16)00017-7
Date:
February, 2016
File:
PDF, 220 KB
english, 2016